Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class III · Low risk

Venlafaxine Hydrochloride

Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.

Terminated Dissolution failure McKesson Packaging Services NDC 63739-0512-10 D-1167-2014
Class III · Low risk

Advil PM Caplets

Subpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.

Terminated Wrong potency / content Pfizer Us Pharmaceutical Group NDC 0573-0164-43 D-1166-2014
Class III · Low risk

Nicorette Lozenge

Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Terminated Wrong potency / content GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline D-1244-2014
Class III · Low risk

Nicotine polacrilex lozenge

Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Terminated Wrong potency / content GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline D-1243-2014
Class III · Low risk

Nicotine polacrilex lozenge

Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Terminated Wrong potency / content GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline D-1242-2014
Class III · Low risk

Nicotine polacrilex lozenge

Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Terminated Wrong potency / content GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline D-1241-2014

Recalls by year